1
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Effects of Treatment Compliance and Overnight Gastric Secretion on Outcome of Maintenance Therapy of Duodenal Ulcer with Ranitidine

, &
Pages 193-200 | Received 26 Apr 1982, Accepted 26 Jul 1982, Published online: 19 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

. (1990) References. Scandinavian Journal of Gastroenterology 25:sup177, pages 99-103.
Read now
E. J. S. Boyd, J. G. Penston & K. G. Wormsley. (1990) Maintenance Therapy of Duodenal and Gastric Ulcer with H2-Receptor Antagonists. Scandinavian Journal of Gastroenterology 25:sup178, pages 72-78.
Read now
H. G. Dammann, S. M. De Looze, W. Bender & R. Labs. (1988) Clinical Characteristics of Roxatidine Acetate: A Review. Scandinavian Journal of Gastroenterology 23:sup146, pages 121-134.
Read now
D. A. Johnston & K. G. Wormsley. (1988) Time of Administration Influences Gastric Inhibitory Effects of Ranitidine. Scandinavian Journal of Gastroenterology 23:9, pages 1137-1140.
Read now
B. Bianchi Porro, M. Lazzaroni, F. Parente & M. Petrillo. (1986) The Influence of Colloidal Bismuth Subcitrate on Duodenal Ulcer Relapse. Scandinavian Journal of Gastroenterology 21:sup122, pages 35-38.
Read now
E. J. S. Boyd, J. A. Wilson & K. G. Wormsley. (1984) The Fate of Asymptomatic Recurrences of Duodenal Ulcer. Scandinavian Journal of Gastroenterology 19:6, pages 808-812.
Read now
E. J. S. Boyd, J. A. Wilson & K. G. Wormsley. (1984) Safety of Ranitidine Maintenance Treatment of Duodenal Ulcer. Scandinavian Journal of Gastroenterology 19:3, pages 394-400.
Read now

Articles from other publishers (14)

Per G. Farup, Thomas A. Hinterleitner, Milan Lukáš, Xavier Hébuterne, Daniel Rachmilewitz, Massimo Campieri, Rémy Meier, Ralf Keller, Barrie Rathbone & Einar Oddsson. (2001) Mesalazine 4 g Daily Given as Prolonged-Release Granules Twice Daily and Four Times Daily Is at Least as Effective as Prolonged-Release Tablets Four Times Daily in Patients with Ulcerative Colitis. Inflammatory Bowel Diseases 7:3, pages 237-242.
Crossref
D. R. Fletcher. (1997) PEPTIC DISEASE: CAN WE AFFORD CURRENT MANAGEMENT?. ANZ Journal of Surgery 67:2-3, pages 75-80.
Crossref
G. DOBRILLA, L. ZANCANELLA & S. AMPLATZ. (2007) The need for long-term treatment of peptic ulcer. Alimentary Pharmacology & Therapeutics 7, pages 3-15.
Crossref
P. G. FARUP. (2007) Compliance with anti‐ulcer medication during short‐term healing phase clinical trials. Alimentary Pharmacology & Therapeutics 6:2, pages 179-186.
Crossref
J.H. LEWIS. (2007) Idiopathic gastric acid hypersecretion: treatment implications for refractory acid/peptic disorders. Alimentary Pharmacology & Therapeutics 5, pages 15-24.
Crossref
Alan L. Buchman. (1991) Cost-effectiveness of mentense H2 blockers in peptic ulcer disease. Gastroenterology 100:2, pages 584.
Crossref
J. H. Lewis. 1991. Pharmacology of Peptic Ulcer Disease. Pharmacology of Peptic Ulcer Disease 263 300 .
Roy Pounder. (1989) Silent Peptic Ulceration: Deadly Silence or Golden Silence?. Gastroenterology 96:2, pages 626-631.
Crossref
E.J.S. Boyd, D.A. Johnston, J.G. Penston & K.G. Wormsley. (1988) DOES MAINTENANCE THERAPY KEEP DUODENAL ULCERS HEALED?. The Lancet 331:8598, pages 1324-1327.
Crossref
M Doherty, R H Hunt, M J Langman, R E Pounder, R I Russell, R D Sturrock & A K Thould. (1987) Management of NSAID induced gastrointestinal disturbance.. Annals of the Rheumatic Diseases 46:8, pages 640-643.
Crossref
Rolf Jorde, Leif Bostad & PerG. Burhol. (1986) ASYMPTOMATIC GASTRIC ULCER: A FOLLOW-UP STUDY IN PATIENTS WITH PREVIOUS GASTRIC ULCER DISEASE. The Lancet 327:8473, pages 119-121.
Crossref
Andre L. Blum. (1985) Therapeutic approach to ulcer healing. The American Journal of Medicine 79:2, pages 8-14.
Crossref
K. G. Wormsley. 1984. H2-Blocker in der Therapie säurebedingter Erkrankungen. H2-Blocker in der Therapie säurebedingter Erkrankungen 14 24 .
K G Wormsley. (1983) Duodenal ulcer: does pathophysiology equal aetiology?. Gut 24:9, pages 775-780.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.